Biologics Pricing Report

2019 Biologics Report Brings Value to Innovators, CDMOs & PE Investors

Biologics CDMO Market Report & Pricing Study

Invaluable Peer Comparison for CDMOs or PE Investors

If you are a CDMO serving the biologics outsourcing market, or a PE company or investor looking to define your investing strategy, you need our Biologics CDMO Market Report & Pricing Study because it will help you to understand your competitive arena, know how you measure up on pricing, and position effectively to get on shortlists. Access pricing data that is typically impossible to come by.

Exceptional Source of Due Diligence & Pricing for Innovators

If you are a innovator – large or small/virtual – looking to outsource your biologics development and manufacturing, you need our Biologics CDMO Market Report & Pricing Study because it is a rich resource for introduction and information on 100+ Biologics CDMOs that might be ideal for you. Understand what you should pay with competitive pricing comparisons.

What You Get With the Report

  • Current 2019 pricing benchmarks based on actual quotes given by providers for all typical service line items within biologic development projects.
  • Ability to measure whether your pricing levels are right against high, low and median pricing in the marketplace.
  • A comprehensive view of the competitive landscape with a directory of the Top 100 Biopharmaceutical CDMOs across major regions today, including capabilities, capacity, proprietary technologies, and locations.
  • Input from subject matter experts (SMEs) from CDMOs and buyers of outsourced services.
  • Projections on ongoing growth of the biologics market, including segmentation such as cell and gene therapy, orphan drugs, etc.
  • Segmented breakdown of the biologics development market by scientific process, therapeutic areas, regions, clinical and commercial production, etc.
  • Analysis of advanced therapeutics in development, novel expression platforms, and advances in technology.

Gain More Understanding Of:

  • High, low and median pricing for all typical Biologics CDMO services
  • Benchmark pricing and capacities among 100 CDMOs in biologics
  • The leading Biologics CDMO providers globally, region to region
  • Where capacity exists worldwide
  • Awareness levels and perceptions of Biologics CDMO providers
  • What matters to buyers of outsourced services / innovators seeking a CDMO
  • Methodologies / processes used to select CDMOs, including consultants

Biologics CDMO Pricing Study

Pricing benchmarks cover line items under:

  • Methodology
  • Discovery / Cell Line Development / IND
  • Analytical Work
  • Engineering / Manufacturing Run
  • Additional Analytical Devvelopment
  • Commercial Manufacturing

Biologics CDMO Market Report

  • Executive Summary
  • Biopharma Market Overview
    • Study Methodology
    • Market Size
    • Biosimilars
  • Biopharma Market by Production Method
    • Mammalian
    • Microbial
    • Other (plant, insect, etc.)
  • Biopharma Market by Production Type:
    Established Products
    • Recombinant Proteins including Antibodies
    • Plasmid Proteins
    • Hormones and Growth Factors
    • Vaccines
  • Biopharma Market by product Type:
    Next Generation Products
    • Next Generation Antibodies
    • Plasma Proteins
    • Viral Vectors
    • Gene Therapies
    • CAR-1 Cell Therapies
    • Stem Cell Therapies
  • Biopharma Market by Development Stage
  • Biopharma Contract Development and Manufacturing Market
  • Market Size by Product Type
    • Established Branded Biologics
    • Biosimilars and Biobetters
    • Vaccines
    • Cell and Gene Therapies
  • Services Offered
    • Cell-line Engineering
    • Development Activities
    • Drug Substance Manufacturing
    • Biopharmaceutical Analysis
    • Fill/Finish
    • Viral Fill/Finish
  • Regional Analysis
  • Recent Investments
  • Competitive Landscape
  • Biopharma Outsourced Manufacturing Pricing Study
    • Methodology
    • Discovery / Cell Line Development / IND
    • Analytical Work
    • Engineering/Manufacturing Run
    • Additional Analytical Development
    • Commercial

For more information:

Order your Report

Over 1,500 Hours of Data Collection & Analysis

  • Study Started:  January 2,2019
  • Data Collection:  February-April 2019
  • Collation & Analysis:  April-May 2019
  • Report Available:  July 16, 2019
  • Page Count:  200+